As of Nov 19, 2026, 2 of 2 active firms rate RRGB a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
RRGB EPS & revenue forecast
EPS · NEXT QUARTER
$-0.11
Range $-0.12 – $-0.10 · 3 analysts · -73% YoY
Next period, 3 analysts expect Red Robin Gourmet Burgers Inc to earn $-0.11 a share (range $-0.12 – $-0.10), versus $-0.41 a year earlier. Full-year consensus is $-0.17, growing to $0.29 the year after.
REVENUE · NEXT QUARTER
$256.8M
Range $250.4M – $260.7M · 3 analysts · -5% YoY
Revenue is expected to reach $256.8M (range $250.4M – $260.7M), -4.5% year-over-year. Full-year consensus is $1.2B, rising to $1.1B next year.
Top analysts covering Red Robin Gourmet Burgers Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on RRGB.
#1
Mark Smith
Lake Street · Rank #525
Buy
$11.00+38.7% to target
Overall win rate
32%
+ Follow
#2
Todd M. Brooks
Benchmark · Rank #544
Buy
$10.00+26.1% to target
Overall win rate
26%
+ Follow
#3
Andy Barish
Jefferies
Buy
$7.00-11.7% to target
Coverage
—
+ Follow
#4
JH
Jeremy Hamblin
Craig-Hallum
Buy
$14.50+82.8% to target
Coverage
—
+ Follow
#5
AS
Alexander Slagle
Jefferies
Buy
$7.00-11.7% to target
Coverage
—
+ Follow
RRGB stock forecast FAQ
What is RRGB's average 12-month price target?+
The 2 active firms with a live target average $8.50 for Red Robin Gourmet Burgers Inc over the next 12 months, ranging from a $10.00 high to a $7.00 low, as of Nov 19, 2026.
Is RRGB stock a Buy, Sell or Neutral right now?+
The current consensus is Insufficient coverage. Of the 2 active firms as of Nov 19, 2026, 2 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for RRGB?+
The Street-high target is $10.00 (Benchmark), and the Street-low is $7.00 (Jefferies). The average of all 2 active-firm targets is $8.50.
How many active Wall Street firms cover RRGB?+
2 active firms have a recognized rating on Red Robin Gourmet Burgers Inc as of Nov 19, 2026, and 2 active firms carry a live 12-month price target.
Who is the most accurate analyst covering RRGB?+
Among analysts who currently cover RRGB, Mark Smith of Lake Street has the strongest overall Quantellect track record (Rank #525). Their current call is Buy with a $11.00 target.
What is Red Robin Gourmet Burgers Inc's projected EPS for next quarter?+
The consensus estimate is $-0.11 per share (range $-0.12 – $-0.10) across 3 analysts. Full-year EPS is projected at $-0.17, rising to $0.29 the following year.
How much revenue is Red Robin Gourmet Burgers Inc expected to report next quarter?+
Consensus revenue is $256.8M (range $250.4M – $260.7M). Full-year revenue is projected at $1.2B, growing to $1.1B next year.
Have analysts been upgrading or downgrading RRGB lately?+
As of Nov 19, 2026, 2 of 2 active firms rate RRGB a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their RRGB calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.